Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous

Figure 1 Cryofibrinogen (CF) concentration in subgroups of 284 patients. ^bP<0.001 for active UC vs healthy control or UC post OP, inactive CD, acute colitis, and other disease control; ^dP< 0.01 for inactive UC and active CD vs healthy control, UC post OP, inactive CD, acute colitis, and other disease control; ^aP<0.05 for collagen disease vs healthy control or UC post OP, inactive CD, acute colitis; ^cP<0.05 for active UC vs inactive UC and active CD; ^eP<0.05 for UC post OP, inactive CD, acute colitis, and other disease control vs healthy control.

Figure 2 Simple regression analysis for relationship between plasma CF concentration and erythrocyte sedimentation rate (ESR) in 69 patients with active IBD.

Figure 3 Logistic regression analysis to determine the relationship between TI and anti-TI-ab in patients with IBD.

Figure 4 Simple regression analysis for the relationship between plasma CF concentration and TI-ab in 18 patients with active IBD.